Methyl 2-[[(4-methoxyphenyl)methylene]amino]benzoate
Common Name: |
Methyl 2-[[(4-methoxyphenyl)methylene]amino]benzoate |
IUPAC Name: |
methyl 2-[(4-methoxyphenyl)methylideneamino]benzoate |
Molecular Formula: |
C16H15NO3 |
SMILES: |
COC1=CC=C(C=C1)C=NC2=CC=CC=C2C(=O)OC |
Inchi: |
1S/C16H15NO3/c1-19-13-9-7-12(8-10-13)11-17-15-6-4-3-5-14(15)16(18)20-2/h3-11H,1-2H3 |
Inchi Key: |
VYSXJKIBCGUXTM-UHFFFAOYSA-N |
Cas No: |
14735-72-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
269.30 |
Mass (g/mol) |
269.105 |
Molar Refractivity |
77.91 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
5 |
Rings |
2 |
TPSA |
47.89 |
Hetero Atoms |
4 |
Heavy Atoms |
20 |
Aromatic Heavy Atoms |
12 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
437.00 to 438.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.12 |
LogP |
3.232 |
iLOGP |
3.04 |
XLOGP3 |
3.05 |
WLOGP |
3.23 |
MLOGP |
2.65 |
ESOL Log S |
-3.55 |
ESOL Solubility (mg/ml) |
0.077 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.72 |
Ali Solubility (mg/ml) |
0.05 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-5.21 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.78 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.833 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
2.181 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
1 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |